Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages
Palak Shah(Alaska Heart and Vascular Institute), Stavros G. Drakos(University of Utah), Shashank Desai(Veterans Health Administration), Guoqing Diao(George Washington University), Michael T. Yin(Columbia University Irving Medical Center), Naila Ijaz(University of the Punjab), James C. Fang, Mitchell A. Psotka(Alaska Heart and Vascular Institute), Craig H. Selzman(University of Utah), Federica Latta(Alaska Heart and Vascular Institute), Iosif Taleb(University of Utah), Josef Stehlik, Lauren B. Cooper, Wei Zhu(Alaska Heart and Vascular Institute), Ramesh Singh(Bon Secours Heart & Vascular Institute), Christos P. Kyriakopoulos(Veterans Health Administration), Christopher W. May(Alaska Heart and Vascular Institute), Mortada Shams(George Washington University), Omar Wever‐Pinzon(University of Utah), Abdallah G. Kfoury(Veterans Health Administration), Rami Alharethi(Intermountain Medical Center)
Cited by 50
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889
Interventions for Frailty Among Older Adults With Cardiovascular Disease
|Journal of the American College of Cardiology|2022|393
HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
|Journal of Cardiac Failure|2024|357